about
Role of endoplasmic reticulum stress in drug-induced toxicityDrug-Induced Metabolic AcidosisWater, electrolytes, and acid-base alterations in human immunodeficiency virus infected patientsDrug safety evaluation of oral tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis for human immunodeficiency virus infection.Gastrointestinal Symptoms in HIV-Infected Patients: Female Sex and Smoking as Risk Factors in an Outpatient Cohort in Brazil.Tenofovir and adefovir down-regulate mitochondrial chaperone TRAP1 and succinate dehydrogenase subunit B to metabolically reprogram glucose metabolism and induce nephrotoxicityAntiviral natural products and herbal medicines.Management of HIV infection in patients with cancer receiving chemotherapy.Effects of combined alcohol and anti-HIV drugs on cellular stress responses in primary hepatocytes and hepatic stellate and kupffer cellsLeptin expression in HIV-infected patients during antiretroviral therapy.Discovery and crystallography of bicyclic arylaminoazines as potent inhibitors of HIV-1 reverse transcriptaseInvestigational reverse transcriptase inhibitors for the treatment of HIV.Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants.Nanogel-Conjugated Reverse Transcriptase Inhibitors and Their Combinations as Novel Antiviral Agents with Increased Efficacy against HIV-1 Infection.Body-drug assemblages: theorizing the experience of side effects in the context of HIV treatment."So far it's been choosing which side effects I want or I can deal with": A grounded theory of HIV treatment side effects among people living with HIV.Antiretroviral Treatment with Efavirenz Disrupts the Blood-Brain Barrier Integrity and Increases Stroke Severity.An Enhanced Emtricitabine-Loaded Long-Acting Nanoformulation for Prevention or Treatment of HIV Infection.A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine ProductsIn vitro and Ex vivo Neurotoxic Effects of Efavirenz are Greater than Those of Other Common Antiretrovirals.Inherited mitochondrial genomic instability and chemical exposures.Dosing antiretroviral medication when crossing time zones: a review.Thymosin alpha 1 and HIV-1: recent advances and future perspectives.Rilpivirine, emtricitabine and tenofovir alafenamide: single-tablet combination for the treatment of HIV-1 infection in selected patients.Recent trends on hydrogel based drug delivery systems for infectious diseasesLow abundance of mitochondrial DNA changes mitochondrial status and renders cells resistant to serum starvation and sodium nitroprusside insult.Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M).Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer.Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients.Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence.Rilpivirine and Doravirine Have Complementary Efficacies Against NNRTI-Resistant HIV-1 Mutants.Anti-HIV Activities and Mechanism of 12-O-Tricosanoylphorbol-20-acetate, a Novel Phorbol Ester from Ostodes katharinae.Frequent Occurrence of Pain and Prescription Opioid Use for Treatment of Pain Among Women with and at Risk for HIV Infection.HIV viral kinetics and T cell dynamics in antiretroviral naïve persons starting an integrase strand transfer inhibitor and protease inhibitor regimen.A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir.Identification of Novel Potential gp120 of HIV-1 Antagonist Using Per-Residue Energy Contribution-Based Pharmacophore modelling.Overdose of dolutegravir in combination with tenofovir disaproxil fumarate/emtricitabine in suicide attempt in a 21-year old patient.Computer-aided design and discovery of protein-protein interaction inhibitors as agents for anti-HIV therapy.Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries.Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment-Clinical Points of View and Practical Considerations.
P2860
Q26765518-0245082F-CBDE-46AC-99E8-79EACEB5C560Q26766204-5FECE899-08C4-4EC5-AA9B-88EB86AEB328Q26770753-FC099356-1B2C-4784-873C-8B502CC77DCDQ30249113-F91253A9-58A1-49B5-8327-5D9D6F290CB0Q33469007-11FEEF5B-CB21-4A5E-B7BE-EEC793890914Q33551834-0DE8AF67-FB09-43EE-A238-AB845CE1E5F2Q33657624-710C9087-0338-478A-B873-922C1326ECF6Q35008342-A00E7F07-EEC5-4970-A00D-9229FE9DE728Q35549547-68F1E41D-403C-4009-B4EA-EEDF6304FA3AQ36062324-0E60C5CB-76BC-4EDE-A419-FF10DE2450A8Q36167147-7973AB1E-A0CA-48FF-B43A-0B79B51A41B4Q36306231-42C5BB44-00A0-4B81-AD4E-763869FDBF3DQ36583683-0AF17357-EFB9-42F9-AC1B-BC10026A4D15Q36942446-31AEE981-F8BF-43C2-B100-C150DD559478Q37280882-3C1BF260-2A2E-49E1-9C86-C629D01F47CBQ37418447-34E6AE50-E88D-40C3-919F-6D724DF2E47AQ37529187-405EAE6A-02D1-462A-9853-AD533B90AFDEQ37538618-26CC36B8-0641-4B8B-B796-F68567F6A587Q38513275-F2C36923-4B5F-4844-806D-BC01A70F4833Q38645161-FF821A02-4786-4685-ABBC-B20E05266595Q38649815-ECCDA8F0-FDCB-418D-ADD3-9A0B755AB44FQ38674015-2EBF8FBE-A0B7-411D-9741-C4A51D8CADC0Q38768132-5E3C5A1C-647D-4DCF-971F-3D365DA7E864Q38802093-8D9A8955-A93F-48BC-8749-C80565822728Q38810357-8EEBDB42-6BEC-4C07-AC51-F4E6F0D7D8DDQ38892858-2D4C4D75-EB62-42C5-AC73-6A8C9C680CF7Q38972140-0129914D-649D-4182-BF9C-8E362B748074Q39020800-B255AD07-DBF3-49FC-B429-291EB623122DQ39097668-520507A7-F9EA-42DB-AD80-86E5E033B775Q39453985-9A3A1FD3-6555-433B-87C3-3C0E226FDA74Q39813922-DC2C7B21-601B-45AF-B8BF-573A67B7B41AQ40051104-8B1E3A28-4E17-4118-A61D-647C895E5D01Q40153349-F92F9C06-D3C8-4E51-BC49-8029CE31FABAQ40353844-FD7EBC15-38A8-4D8D-9751-90A88209D021Q40517770-14021531-95B0-4CCC-8E3D-B64FFEAC8D5EQ40680044-66679D8A-7DD0-4AA3-B9BE-D21B99663371Q41183328-E1598314-FE00-4732-ADC0-80D6E1C54A83Q42225889-867242FE-A5E7-4CF3-A88E-81166715E2A7Q46499496-ECFD8A40-80FC-4B4E-8AEB-9729FA78621CQ47104527-733815D5-393E-49BA-8FE3-3847C3136A35
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A review of the toxicity of HIV medications.
@en
A review of the toxicity of HIV medications.
@nl
type
label
A review of the toxicity of HIV medications.
@en
A review of the toxicity of HIV medications.
@nl
prefLabel
A review of the toxicity of HIV medications.
@en
A review of the toxicity of HIV medications.
@nl
P2093
P2860
P1476
A review of the toxicity of HIV medications.
@en
P2093
Andrew Stolbach
Asa M Margolis
Harry Heverling
Paul A Pham
P2860
P2888
P356
10.1007/S13181-013-0325-8
P577
2014-03-01T00:00:00Z